This article and associated images are based on a poster originally authored by Denise Sullivan, Zhong Yu, Benjamin Streeter, Stacie Chvatal and Daniel Millard and presented at ELRIG Drug Discovery ...
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records ...
Serplulimab achieves pharmacodynamic saturation, supporting its current clinical use without the need for higher doses. The ASTRUM-005 trial established serplulimab as the PD-1 inhibitor with the ...
In a recent study published in the journal EClinicalMedicine, a team of Chinese researchers conducted a systematic review and meta-analysis to understand the dose-response relationship between ...
Effect on Travel Distance of a Statewide Regionalization Policy for Initial Breast Cancer Surgery The use of 90 mg/m 2 daunorubicin once daily in the context of classical 7 + 3 induction does not ...